PBT-6, a Novel PI3KC2γ Inhibitor in Rheumatoid Arthritis

Phosphoinositide 3-kinase (PI3K) is considered as a promising therapeutic target for rheumatoid arthritis (RA) because of its involvement in inflammatory processes. However, limited studies have reported the involvement of PI3KC2γ in RA, and the underlying mechanism remains largely unknown. Therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Juyoung, Jung, Kyung Hee, Yoo, Jaeho, Park, Jung Hee, Yan, Hong Hua, Fang, Zhenghuan, Lim, Joo Han, Kwon, Seong-Ryul, Kim, Myung Ku, Park, Hyun-Ju, Hong, Soon-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059814/
https://www.ncbi.nlm.nih.gov/pubmed/31739383
http://dx.doi.org/10.4062/biomolther.2019.153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059814/
https://www.ncbi.nlm.nih.gov/pubmed/31739383
http://dx.doi.org/10.4062/biomolther.2019.153

Ejemplares similares